Loading clinical trials...
Loading clinical trials...
To compare the safety and efficacy of two treatment regimens: 1) COL-101 and metronidazole gel 1%; 2) Doxycycline hyclate 100 mg and metronidazole gel 1%
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
CollaGenex Pharmaceuticals
NCT07106957 · Erythematous Telangiectatic Rosacea
NCT06466018 · Ocular Rosacea, Pachychoroid Disease
NCT05296837 · Ocular Rosacea, Antimicrobial Resistance
NCT04108897 · Rosacea
NCT07250165 · Rosacea
Joel Schlessinger
Omaha, Nebraska
James Del Rosso
Las Vegas, Nevada
Angela Moore
Arlington, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions